Re Director Dealings

RNS Number : 1580G

Futura Medical PLC

26 January 2010

 





For immediate release

26 January 2010

Futura Medical plc

("Futura" or "the Company")

 Correction of Director's Dealings

Futura Medical plc (AIM: FUM) announces a correction to its director's dealing announcement of 17 December 2009 (the "Original Announcement"). 

In the Original Announcement James Barder's aggregate beneficial and non-beneficial holdings was described as "unchanged at 720,212 ordinary shares". This number should have been stated as "unchanged at 845,212 ordinary shares".  This is a correction and does not reflect any change to Mr Barder's actual holding.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Stasa Filiplic / Jennie Spivey	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com 

 

END

 

 

MSCPGUUUGUPUGQQ